ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies
ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce +72 more
wiley +1 more source
The effect of client-auditor mismatches on earnings management using classification shifting: Evidence from China. [PDF]
Luo S, Yu D, Jin S.
europepmc +1 more source
A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling +16 more
wiley +1 more source
Enhancing Food Safety and Infection Control in Mass Foodservice Operations: Implementing a Foodservice Provision Audit Tool for Sport (FPAT-S). [PDF]
Dufour AC +3 more
europepmc +1 more source
Corporate governance and reporting quality of accounts in China-listed firms. A moderating role of ownership pattern. [PDF]
Sun H.
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
ReFaceX: donor-driven reversible face anonymisation with detached recovery. [PDF]
Muhammad D +3 more
europepmc +1 more source
Assessing the reliability of pediatric emergency medicine billing code assignment for future consideration as a proxy workload measure. [PDF]
Park JM +4 more
europepmc +1 more source
AUDITOR VERSUS MODEL - INFORMATION CHOICE AND INFORMATION-PROCESSING
AUDITOR VERSUS MODEL - INFORMATION CHOICE AND INFORMATION ...
Roger Simnett (13091970) +1 more
core

